VALEO financials
VALEO
Country: FR Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
5493006IH2N2WMIBB742 ISIN: FR0013176526 Financial statements
(EUR, as reported — unscaled; 119 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €20.90B | €21.49B |
| Cost of sales | €16.67B | €17.41B |
| Administrative expenses | €704.0M | €739.0M |
| Profit before tax | €460.0M | €333.0M |
| Income tax expense | €205.0M | €99.0M |
| Profit for the year | €255.0M | €234.0M |
| — attributable to owners | €200.0M | €162.0M |
| — attributable to NCI | €55.0M | €72.0M |
| Total comprehensive income | -€309.0M | €269.0M |
| Per share | ||
| Basic EPS | €0.82 | €0.67 |
| Diluted EPS | €0.81 | €0.66 |
| Free cash flow / share | €4.76 | €4.37 |
| Cash flow statement | ||
| Net cash from operating activities | €2.29B | €2.69B |
| Net cash from investing activities | -€1.57B | -€1.95B |
| Purchase of PP&E (capex) | €790.0M | €1.14B |
| Purchase of intangibles | €971.0M | €1.09B |
| Net cash from financing activities | -€1.16B | -€524.0M |
| Dividends paid | €143.0M | €139.0M |
| Balance sheet | ||
| Total assets | €20.27B | €21.66B |
| Non-current assets | €12.12B | €12.78B |
| Intangible assets & goodwill | €2.99B | €3.09B |
| Current assets | €8.15B | €8.88B |
| Inventories | €1.86B | €2.11B |
| Trade & other receivables | €2.96B | €2.66B |
| Cash & equivalents | €2.48B | €3.15B |
| Total equity | €4.07B | €4.51B |
| — attributable to owners | €3.32B | €3.72B |
| Non-controlling interests | €750.0M | €796.0M |
| Non-current liabilities | €6.68B | €6.16B |
| Long-term borrowings | €5.43B | €4.86B |
| Current liabilities | €9.52B | €10.99B |
| Current portion of long-term borrowings | €484.0M | €1.33B |
| Deferred tax liabilities | €68.0M | €48.0M |
| Derived metrics | ||
| Free cash flow | €1.50B | €1.55B |
| Net margin | 1.2% | 1.1% |
| Return on equity | 6.3% | 5.2% |
| Cash conversion ratio | 8.98× | 11.48× |
| Capex coverage | 2.90× | 2.36× |
| Other reported items | ||
| Adjustments For Finance Income Cost | -€256.0M | -€251.0M |
| Adjustments For Income Tax Expense | €205.0M | €99.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€20.0M | €12.0M |
| Bank Overdrafts Classified As Cash Equivalents | €51.0M | €4.0M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €2.43B | €3.15B |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €79.0M | €211.0M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€239.0M | -€88.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €2.88B | €2.42B |
| Commercial Papers Issued | €594.0M | €840.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | -€6.0M | €50.0M |
| Comprehensive Income Attributable To Owners of Parent | -€303.0M | €219.0M |
| Current Government Grants | €54.0M | €66.0M |
| Current Provisions For Employee Benefits | €77.0M | €79.0M |
| Current Tax Assets Current | €58.0M | €64.0M |
| Current Tax Liabilities Current | €142.0M | €124.0M |
| Deferred Tax Assets | €805.0M | €740.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €103.0M | €97.0M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €40.0M | €42.0M |
| Dividends Received Classified As Operating Activities | €9.0M | €15.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€279.0M | €32.0M |
| Equity and Liabilities | €20.27B | €21.66B |
| Gains Losses On Cash Flow Hedges Net of Tax | €60.0M | €11.0M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €8.0M | -€29.0M |
| Income Tax Relating To Investments In Equity Instruments of Other Comprehensive Income | €0 | €0 |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €5.0M | €13.0M |
| Income Tax Relating To Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss | €0 | €0 |
| Income Tax Relating To Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss | €0 | €0 |
| Income Taxes Paid Refund Classified As Operating Activities | €287.0M | €227.0M |
| Increase Decrease In Cash and Cash Equivalents | -€720.0M | €259.0M |
| Increase Decrease In Working Capital | €301.0M | -€492.0M |
| Increase Decrease Through Sharebased Payment Transactions | €32.0M | €22.0M |
| Increase Decrease Through Transactions With Owners | -€135.0M | -€114.0M |
| Increase Decrease Through Transfers and Other Changes Equity | -€7.0M | €32.0M |
| Increase Decrease Through Treasury Share Transactions | -€25.0M | -€25.0M |
| Intangible Assets Other Than Goodwill | €3.23B | €3.32B |
| Interest Paid Classified As Financing Activities | €294.0M | €307.0M |
| Investment Accounted For Using Equity Method | €64.0M | €110.0M |
| Issue of Equity | €8.0M | €0 |
| Issued Capital | €246.0M | €245.0M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €16.0M | €47.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €25.0M | €104.0M |
| Noncurrent Government Grants | €147.0M | €149.0M |
| Noncurrent Provisions For Employee Benefits | €698.0M | €782.0M |
| Number of Shares Outstanding | 243.0M | 243.0M |
| Other Adjustments For Noncash Items | €2.13B | €1.83B |
| Other Comprehensive Income | -€564.0M | €35.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€640.0M | €88.0M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | €0 | €0 |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €52.0M | -€7.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€616.0M | €42.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €52.0M | -€7.0M |
| Other Current Financial Assets | €112.0M | €89.0M |
| Other Current Financial Liabilities | €25.0M | €41.0M |
| Other Current Payables | €2.44B | €2.50B |
| Other Current Receivables | €659.0M | €699.0M |
| Other Finance Income Cost | -€73.0M | -€34.0M |
| Other Longterm Provisions | €335.0M | €316.0M |
| Other Noncurrent Financial Assets | €335.0M | €395.0M |
| Other Noncurrent Financial Liabilities | €1.0M | €2.0M |
| Other Operating Income Expense | -€168.0M | -€313.0M |
| Other Shortterm Provisions | €541.0M | €573.0M |
| Payments From Changes In Ownership Interests In Subsidiaries | €0 | €0 |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €90.0M | €21.0M |
| Proceeds From Government Grants Classified As Investing Activities | €33.0M | €67.0M |
| Proceeds From Issuing Shares | €8.0M | €0 |
| Proceeds From Noncurrent Borrowings | €1.30B | €858.0M |
| Property Plant and Equipment Including Rightofuse Assets | €4.67B | €5.10B |
| Purchase of Interests In Investments Accounted For Using Equity Method | €1.0M | €0 |
| Purchase of Other Longterm Assets Classified As Investing Activities | €8.0M | €27.0M |
| Reclassification Adjustments On Cash Flow Hedges Net of Tax | €27.0M | €58.0M |
| Recognised Assets Defined Benefit Plan | €29.0M | €31.0M |
| Repayments of Noncurrent Borrowings | €1.85B | €896.0M |
| Research and Development Expense | €2.27B | €2.13B |
| Reserve of Exchange Differences On Translation | -€626.0M | -€33.0M |
| Retained Earnings | €2.11B | €1.92B |
| Selling Expense | €275.0M | €296.0M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | -€9.0M | €1.0M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | €0 | €0 |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€20.0M | €12.0M |
| Share Premium | €1.59B | €1.59B |
| Trade and Other Current Payables To Trade Suppliers | €5.10B | €5.38B |
Methodology
Every line item above is a fact tagged in VALEO's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.